S&P 500 ^GSPC
5,032.04
-0.38%
Nvidia NVDA
$845.69
-3.26%
Amazon AMZN
$181.41
-1.04%
Meta META
$495.54
-0.84%
Alphabet GOOG
$157.11
+0.71%
Apple AAPL
$168.44
-0.56%
Tesla TSLA
$156.29
-0.52%
Microsoft MSFT
$413.01
-0.38%

Pfizer $PFE-0.7% reported results today. You could say that the results beat expectations, but the revenue just missed expectations. Revenue was down from Q1 this year as sales of the Covid-19 vaccine fell 83% and revenue from the Paxlovide antiviral treatment fell 98%.

I've been buying $PFE-0.7% shares recently as they are currently at a really low price.

Do you have shares of $PFE-0.7% included in your portfolio?

PFE

Pfizer

PFE
$25.51 -$0.18 -0.70%
Capital Structure
Market Cap
145.1B
Enterpr. Val.
217.5B
Valuation
P/E
69.4
P/S
2.5
Dividends
Yield
6.4%
Payout
433.7%

Somehow I'm not attracted to this company, so I'm not including

I have PFE and will probably add more. It's at a pre-covid price, which I think indicates it's undervalued. 4.5% divi yield, which is great covered by free cash is great too.

I thought some of their medicine they put in didn't pass or am I wrong? On the other hand, they'll probably have a lot of other ones:)

Recently, an obesity drug failed after tests, but they're already working on an alternative, which they should introduce in the fall, if I remember correctly. For my part, nothing happens if a drug doesn't work out. On the other hand, if it works, it's a bomb.

Great, I will also be buying more and I like the dividend too.

The price is the same as before covid, but FCF is already elsewhere. That speaks for itself, I'd say. 👍